BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3906644)

  • 1. [Activity and specificity of tuberculins derived from BCG culture filtrates].
    Levi DT; Iablokova TB; Altynova MP; Mitinskaia LA; Bardina EE
    Probl Tuberk; 1985; (9):60-3. PubMed ID: 3906644
    [No Abstract]   [Full Text] [Related]  

  • 2. [Variability of the BCG Moreau substrain. II. Comparison of the allergizing and protective properties of BCG substrains of various origins].
    Janaszek W
    Med Dosw Mikrobiol; 1983; 35(2):97-105. PubMed ID: 6369043
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model.
    Dannenberg AM
    Tuberculosis (Edinb); 2001; 81(1-2):87-96. PubMed ID: 11463228
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of biological potencies of different tuberculins.
    Levy DT; Jablokova TB
    Dev Biol Stand; 1986; 58 ( Pt B)():581-4. PubMed ID: 3111904
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycobacterial sensitivity elicited with a PPD devoided of the majority of the antigens common with BCG. Results on healthy-BCG vaccinated and tuberculous children.
    Stavri D; Claiciu I; Bărbulescu R; Stavri H; Niculescu D; Calciu B; Calciu M
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):221-6. PubMed ID: 6424630
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the recombinant 38 kDa protein of Mycobacterium tuberculosis.
    He XY; Luo YA; Zhang XG; Liu YD; Wang ZY; Luo FZ; Zhang JP; Wang Q; Yan SM; Wang YJ; Ma LF; Guo J; Dong YJ; Huang XY; Zhuang YH
    Scand J Infect Dis; 2008; 40(2):121-6. PubMed ID: 17852901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological properties of cellular membranes of Mycobacterium bovis].
    Romanova RIu; Pavlova VT; Il'ina IN; Kliuev VA
    Probl Tuberk; 1978 Aug; (8):67-70. PubMed ID: 360207
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies of 5 G substrains. II. Tuberculin sensitization with 5 BCG vaccines].
    Paraschivesco M; Gheorghiu M; Petrovici-Venson E
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):541-4. PubMed ID: 4923822
    [No Abstract]   [Full Text] [Related]  

  • 11. Qualitative effect of BCG vaccination on sensitivity to typical and atypical tuberculins.
    Crispen RG
    Dev Biol Stand; 1986; 58 ( Pt B)():645-53. PubMed ID: 3609458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bcg strains for delayed hypersensitivity induction tested in vivo in guinea pigs and in vitro.
    Smerák P; Průchová J; Sír Z
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):435-44. PubMed ID: 6761395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Testing post-vaccination and post-infection hypersensitivity with the use of tuberculin PPD-S BCG Polska. I. Use of tuberculin PPD-S BCG in children vaccinated with BCG vaccine].
    Krzyszkowska A; Rzucidło L; Zelechowska M; Wasowska J; Firko-Stepniewska O; Górski S; Szumilak I
    Pneumonol Pol; 1982 Nov; 50(11):599-607. PubMed ID: 7182815
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination.
    Tree JA; Elmore MJ; Javed S; Williams A; Marsh PD
    Infect Immun; 2006 Feb; 74(2):1436-41. PubMed ID: 16428800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of TAS-1D3, a tuberculin-active substance from BCG, in regard to delayed hypersensitivity.
    Yano O; Toizumi S; Sudo T
    Microbiol Immunol; 1984; 28(10):1149-57. PubMed ID: 6441106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of interferon by stimulation with tuberculin in mice previously infected with Mycobacterium tuberculosis strain BCG.
    Shibukawa N; Hashimoto H; Shibusawa A; Kojima Y
    Kitasato Arch Exp Med; 1977 Jun; 50(1-2):23-9. PubMed ID: 357822
    [No Abstract]   [Full Text] [Related]  

  • 17. [BCG: symposium].
    Takase Y; Kayaba K; Kobayashi T; Horai Z; Yokoi M
    Kekkaku; 1970 Nov; 45(11):390-2. PubMed ID: 4924414
    [No Abstract]   [Full Text] [Related]  

  • 18. Potency testing of bovine tuberculins.
    Haagsma J
    Dev Biol Stand; 1986; 58 ( Pt B)():689-94. PubMed ID: 3609463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-lasting enhancing effect of anti-tuberculin antiserum on delayed-type hypersensitivity reaction in BCG-infected guinea pigs.
    Mauch H; Hammer HJ; Kümel G
    Immunobiology; 1980 Jan; 156(4-5):477-82. PubMed ID: 6989751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculin and BCG tests.
    Rajajee S
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S9-13. PubMed ID: 11129911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.